Revenue
2022
2023
2024
2025
Valirx plc (VAL)
Price£0.0014Cached quote
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | £31,372 | £49,775 | £9,600 | £0 | — |
| Research & development | £229,378 | £245,163 | £383,362 | £551,233 | — |
| Operating expenses | £1.8M | £2.1M | £2.3M | £2.6M | — |
| Operating income | −£1.8M | −£2.1M | −£2.3M | −£2.6M | — |
| Operating margin | −5,809.21% | −4,302.70% | −23,943.11% | — | — |
| EBITDA | −£2.2M | −£1.9M | −£2.0M | −£2.4M | — |
| EBITDA margin | −6,939.28% | −3,741.20% | −21,295.17% | — | — |
| Net income | −£2.2M | −£1.9M | −£2.0M | −£2.4M | — |
| Net profit margin | −7,115.13% | −3,848.71% | −21,226.05% | — | — |
| Basic EPSper basic share | -£0.01 | — | -£0.02 | -£0.03 | -£0.02 |
| Diluted EPSper diluted share | -£0.01 | — | -£0.02 | -£0.03 | -£0.02 |